In commemoration of World Cancer Day, the University College Hospital (UCH), Ibadan, has made a groundbreaking achievement in the fight against prostate cancer.
The hospital’s Department of Nuclear Medicine has successfully established a routine availability of Prostate Specific Membrane Antigen (PSMA) imaging and Lutetium-177 PSMA therapy clinic, offering advanced personalized diagnostics and treatment for prostate cancer patients.This milestone marks a significant shift in Nigeria’s healthcare landscape, as patients no longer need to travel abroad to access these specialized services.
The UCH’s Nuclear Medicine team, comprising globally credentialed experts, has made this possible through their dedication and hard work.The PSMA SPECT imaging scan allows for the detection and staging of prostate cancer at a molecular level, ensuring accurate diagnostic staging and treatment.
The Lutetium-177 PSMA therapy is a targeted treatment for advanced prostate cancer, delivering radiation directly to cancer cells while sparing normal surrounding cells.Healthcare professionals involved in prostate cancer care are encouraged to refer patients who may benefit from these services. The hospital has provided an online link (bit.ly/UCHLu177PSMA) for easy referrals.
This achievement is a testament to the University College Hospital, Ibadan in line with the Federal Ministry of Health growing capacity to provide world-class healthcare services. As the country continues to bridge the care gap, patients and families can look forward to improved outcomes and enhanced quality of life.
